Study protocol for development and validation of a single tool to assess risks of stroke, diabetes mellitus, myocardial infarction and dementia: DemNCD-Risk

Introduction Current efforts to reduce dementia focus on prevention and risk reduction by targeting modifiable risk factors. As dementia and cardiometabolic non-communicable diseases (NCDs) share risk factors, a single risk-estimating tool for dementia and multiple NCDs could be cost-effective and f...

Full description

Bibliographic Details
Main Authors: Miia Kivipelto, Ruth Peters, Kaarin J Anstey, Louisa Jorm, Kim M Kiely, Nicola T Lautenschlager, Craig S Anderson, Jonathan E Shaw, Rachel A Whitmer, Fiona Matthews, Md Hamidul Huque, Scherazad Kootar
Format: Article
Language:English
Published: BMJ Publishing Group 2023-09-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/13/9/e076860.full
_version_ 1797669052569616384
author Miia Kivipelto
Ruth Peters
Kaarin J Anstey
Louisa Jorm
Kim M Kiely
Nicola T Lautenschlager
Craig S Anderson
Jonathan E Shaw
Rachel A Whitmer
Fiona Matthews
Md Hamidul Huque
Scherazad Kootar
author_facet Miia Kivipelto
Ruth Peters
Kaarin J Anstey
Louisa Jorm
Kim M Kiely
Nicola T Lautenschlager
Craig S Anderson
Jonathan E Shaw
Rachel A Whitmer
Fiona Matthews
Md Hamidul Huque
Scherazad Kootar
author_sort Miia Kivipelto
collection DOAJ
description Introduction Current efforts to reduce dementia focus on prevention and risk reduction by targeting modifiable risk factors. As dementia and cardiometabolic non-communicable diseases (NCDs) share risk factors, a single risk-estimating tool for dementia and multiple NCDs could be cost-effective and facilitate concurrent assessments as compared with a conventional single approach. The aim of this study is to develop and validate a new risk tool that estimates an individual’s risk of developing dementia and other NCDs including diabetes mellitus, stroke and myocardial infarction. Once validated, it could be used by the public and general practitioners.Methods and analysis Ten high-quality cohort studies from multiple countries were identified, which met eligibility criteria, including large representative samples, long-term follow-up, data on clinical diagnoses of dementia and NCDs, recognised modifiable risk factors for the four NCDs and mortality data. Pooled harmonised data from the cohorts will be used, with 65% randomly allocated for development of the predictive model and 35% for testing. Predictors include sociodemographic characteristics, general health risk factors and lifestyle/behavioural risk factors. A subdistribution hazard model will assess the risk factors’ contribution to the outcome, adjusting for competing mortality risks. Point-based scoring algorithms will be built using predictor weights, internally validated and the discriminative ability and calibration of the model will be assessed for the outcomes. Sensitivity analyses will include recalculating risk scores using logistic regression.Ethics and dissemination Ethics approval is provided by the University of New South Wales Human Research Ethics Committee (UNSW HREC; protocol numbers HC200515, HC3413). All data are deidentified and securely stored on servers at Neuroscience Research Australia. Study findings will be presented at conferences and published in peer-reviewed journals. The tool will be accessible as a public health resource. Knowledge translation and implementation work will explore strategies to apply the tool in clinical practice.
first_indexed 2024-03-11T20:38:34Z
format Article
id doaj.art-ab347e2eb8634c548fb80a26edbe0e04
institution Directory Open Access Journal
issn 2044-6055
language English
last_indexed 2024-03-11T20:38:34Z
publishDate 2023-09-01
publisher BMJ Publishing Group
record_format Article
series BMJ Open
spelling doaj.art-ab347e2eb8634c548fb80a26edbe0e042023-10-02T04:15:07ZengBMJ Publishing GroupBMJ Open2044-60552023-09-0113910.1136/bmjopen-2023-076860Study protocol for development and validation of a single tool to assess risks of stroke, diabetes mellitus, myocardial infarction and dementia: DemNCD-RiskMiia Kivipelto0Ruth Peters1Kaarin J Anstey2Louisa Jorm3Kim M Kiely4Nicola T Lautenschlager5Craig S Anderson6Jonathan E Shaw7Rachel A Whitmer8Fiona Matthews9Md Hamidul Huque10Scherazad Kootar11Division of Geriatric Epidemiology, Karolinska Institutet, Stockholm, SwedenUniversity of New South Wales, Sydney, New South Wales, AustraliaNeuroscience Research Australia, Randwick, New South Wales, AustraliaCentre for Big Data Research in Health, University of New South Wales, Randwick, New South Wales, AustraliaNeuroscience Research Australia, Randwick, New South Wales, AustraliaOlder Adult Mental Health Program, Royal Melbourne Hospital Mental Health Service, Parkville, Victoria, AustraliaThe George Institute for Global Health, George Institute for Global Health, Newtown, New South Wales, AustraliaClinical and Population Health, Baker Heart and Diabetes Institute, Melbourne, Victoria, AustraliaUniversity of California Davis, Davis, California, USAPopulation Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UKNeuroscience Research Australia, Randwick, New South Wales, AustraliaNeuroscience Research Australia, Randwick, New South Wales, AustraliaIntroduction Current efforts to reduce dementia focus on prevention and risk reduction by targeting modifiable risk factors. As dementia and cardiometabolic non-communicable diseases (NCDs) share risk factors, a single risk-estimating tool for dementia and multiple NCDs could be cost-effective and facilitate concurrent assessments as compared with a conventional single approach. The aim of this study is to develop and validate a new risk tool that estimates an individual’s risk of developing dementia and other NCDs including diabetes mellitus, stroke and myocardial infarction. Once validated, it could be used by the public and general practitioners.Methods and analysis Ten high-quality cohort studies from multiple countries were identified, which met eligibility criteria, including large representative samples, long-term follow-up, data on clinical diagnoses of dementia and NCDs, recognised modifiable risk factors for the four NCDs and mortality data. Pooled harmonised data from the cohorts will be used, with 65% randomly allocated for development of the predictive model and 35% for testing. Predictors include sociodemographic characteristics, general health risk factors and lifestyle/behavioural risk factors. A subdistribution hazard model will assess the risk factors’ contribution to the outcome, adjusting for competing mortality risks. Point-based scoring algorithms will be built using predictor weights, internally validated and the discriminative ability and calibration of the model will be assessed for the outcomes. Sensitivity analyses will include recalculating risk scores using logistic regression.Ethics and dissemination Ethics approval is provided by the University of New South Wales Human Research Ethics Committee (UNSW HREC; protocol numbers HC200515, HC3413). All data are deidentified and securely stored on servers at Neuroscience Research Australia. Study findings will be presented at conferences and published in peer-reviewed journals. The tool will be accessible as a public health resource. Knowledge translation and implementation work will explore strategies to apply the tool in clinical practice.https://bmjopen.bmj.com/content/13/9/e076860.full
spellingShingle Miia Kivipelto
Ruth Peters
Kaarin J Anstey
Louisa Jorm
Kim M Kiely
Nicola T Lautenschlager
Craig S Anderson
Jonathan E Shaw
Rachel A Whitmer
Fiona Matthews
Md Hamidul Huque
Scherazad Kootar
Study protocol for development and validation of a single tool to assess risks of stroke, diabetes mellitus, myocardial infarction and dementia: DemNCD-Risk
BMJ Open
title Study protocol for development and validation of a single tool to assess risks of stroke, diabetes mellitus, myocardial infarction and dementia: DemNCD-Risk
title_full Study protocol for development and validation of a single tool to assess risks of stroke, diabetes mellitus, myocardial infarction and dementia: DemNCD-Risk
title_fullStr Study protocol for development and validation of a single tool to assess risks of stroke, diabetes mellitus, myocardial infarction and dementia: DemNCD-Risk
title_full_unstemmed Study protocol for development and validation of a single tool to assess risks of stroke, diabetes mellitus, myocardial infarction and dementia: DemNCD-Risk
title_short Study protocol for development and validation of a single tool to assess risks of stroke, diabetes mellitus, myocardial infarction and dementia: DemNCD-Risk
title_sort study protocol for development and validation of a single tool to assess risks of stroke diabetes mellitus myocardial infarction and dementia demncd risk
url https://bmjopen.bmj.com/content/13/9/e076860.full
work_keys_str_mv AT miiakivipelto studyprotocolfordevelopmentandvalidationofasingletooltoassessrisksofstrokediabetesmellitusmyocardialinfarctionanddementiademncdrisk
AT ruthpeters studyprotocolfordevelopmentandvalidationofasingletooltoassessrisksofstrokediabetesmellitusmyocardialinfarctionanddementiademncdrisk
AT kaarinjanstey studyprotocolfordevelopmentandvalidationofasingletooltoassessrisksofstrokediabetesmellitusmyocardialinfarctionanddementiademncdrisk
AT louisajorm studyprotocolfordevelopmentandvalidationofasingletooltoassessrisksofstrokediabetesmellitusmyocardialinfarctionanddementiademncdrisk
AT kimmkiely studyprotocolfordevelopmentandvalidationofasingletooltoassessrisksofstrokediabetesmellitusmyocardialinfarctionanddementiademncdrisk
AT nicolatlautenschlager studyprotocolfordevelopmentandvalidationofasingletooltoassessrisksofstrokediabetesmellitusmyocardialinfarctionanddementiademncdrisk
AT craigsanderson studyprotocolfordevelopmentandvalidationofasingletooltoassessrisksofstrokediabetesmellitusmyocardialinfarctionanddementiademncdrisk
AT jonathaneshaw studyprotocolfordevelopmentandvalidationofasingletooltoassessrisksofstrokediabetesmellitusmyocardialinfarctionanddementiademncdrisk
AT rachelawhitmer studyprotocolfordevelopmentandvalidationofasingletooltoassessrisksofstrokediabetesmellitusmyocardialinfarctionanddementiademncdrisk
AT fionamatthews studyprotocolfordevelopmentandvalidationofasingletooltoassessrisksofstrokediabetesmellitusmyocardialinfarctionanddementiademncdrisk
AT mdhamidulhuque studyprotocolfordevelopmentandvalidationofasingletooltoassessrisksofstrokediabetesmellitusmyocardialinfarctionanddementiademncdrisk
AT scherazadkootar studyprotocolfordevelopmentandvalidationofasingletooltoassessrisksofstrokediabetesmellitusmyocardialinfarctionanddementiademncdrisk